Glecaprevir

Synonym

Product Category

Product Code

CAS Number

MDL Number

Pubchem CID

Reaxys RN

ABT-493

API & Intermediates

KAPI4F02

1365970-03-1

66828839

image-155171-Trimethyl(trifluoromethyl)silane_reagent.png

Specification
Applications
Safety & Regulations
Product Documents

Chemical Name

Molecular Formula

Molecular Weight

Assay

Appearance

Melting Point

Packaging

Storage

Glecaprevir

C38H46F4N6O9S

838.87

≥99%(HPLC)

White to Off-white Solid

500mg,1g,5g and 10g

-20°C Freezer

Glecaprevir (Synonyms: ABT-493) is a NS 3/4A protease inhibitor potentially for the treatment of Hepatitis C Virus (HCV) infection.

High Efficacy of ABT-493 and ABT-530 Treatment in Patients With HCV Genotype 1 or 3 Infection and Compensated Cirrhosis. [1]

Glecaprevir and pibrentasvir for 12 weeks for hepatitis C virus genotype 1 infection and prior direct-acting antiviral treatment. [2]

In Vitro Antiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS3/4A Protease Inhibitor Glecaprevir. [3]

References:

[1] E.Gane, et al, Gastroenterology, 2016, 151(4), pp 651-659.

[2] F.Poordad, et al, Hepatology, 2017, 61(2), pp 389-397.

[3] TI.Ng, et al Antimicrob. Agents Chemother., 2017, 62(1), pii: e01620-17.

Signal Word

Hazard Statements

Precautionary Statements

HS Code

RIDADR

Legal Information

Not classified as a dangerous goods

2934990300

NONH for all modes of transport

Sales restrictions may apply.

1. Product Specification

Available on request.

2. Safety Data Sheet

Available on request.

Please inquire for pricing and availability of this product by writing email to sales@kumidas.com.